Advanced Enzyme Technologies Q4 Results
- BSE: 540025
- NSE: ADVENZYMES
- ISIN: INE837H01020
- Sector: Biotechnology & Drugs
BSE
339.15
-0.60 (-0.18%)
-0.60 (-0.18%)Volume5.09 L
Updated: Mon 20 Jan, 2025 | 15:28:50
NSE
340.35
0.50 (0.15%)
0.50 (0.15%)Volume7.41 L
Updated: Mon 20 Jan, 2025 | 15:43:13
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Advanced Enzyme Technologies Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 23 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 157.81 | 160.94 | -1.94% | 138.71 | 13.77% |
| Selling/ General/ Admin Expenses Total | 32.48 | 32.13 | 1.10% | 29.96 | 8.40% |
| Depreciation/ Amortization | 9.28 | 8.60 | 7.81% | 8.45 | 9.79% |
| Other Operating Expenses Total | 34.45 | 39.98 | -13.84% | 31.03 | 11.01% |
| Total Operating Expense | 126.85 | 115.78 | 9.57% | 107.07 | 18.47% |
| Operating Income | 30.96 | 45.16 | -31.44% | 31.64 | -2.13% |
| Net Income Before Taxes | 39.61 | 58.88 | -32.72% | 42.10 | -5.92% |
| Net Income | 28.31 | 41.77 | -32.23% | 32.12 | -11.87% |
| Diluted Normalized EPS | 3.54 | 3.74 | -5.23% | 3.16 | 12.28% |